70 likes | 80 Views
Explore the profound effect of TB/HIV co-infection on individuals and populations, highlighting the need for new tools and discussing potential strategies to reduce incidence. This includes a focus on diagnostic advancements, drug development, and vaccine research.
E N D
TB/HIV: Impact and Opportunities Helene Gayle, MD, MPH Bill and Melinda Gates Foundation DATE, 2004
HIV/TB: Profound Effect on Individuals The annual risk of TB in HIV infected approximates the lifetime risk of HIV uninfected Small and Fujiwara, N Eng J Med 343:189, 2001
HIV/TB: Profound Effect on Populations Kenyon et al., Int J TB Lung Dis 1999;3:4-11
HIV/TB: Profound Effect on Populations WHO TB Surveillance Report, 2003
TB/HIV Co-Authorship Network Separate Responses Medline 97-01 TB 12,352 HIV 43,455 “Top” 50 authors Abernethy and Small, unpublished
C R E A E A Coordinated Response To design, implement and evaluate a portfolio of community level trials of new strategies to reduce tuberculosis incidence in populations with high rates of HIV and TB co-infection.
TB/HIV Ultimate Need for New Tools Reaping the benefits of science FIND/TDR for diagnostics ($30M) Global Alliance for new drug ($25 M) Aeras for vaccines ($83M)